title: Low-intensity aerobic interval training attenuates pathological left ventricular remodeling and mitochondrial dysfunction in aortic-banded miniature swine.
abstract: Cardiac hypertrophy in response to hypertension or myocardial infarction is a pathological indicator associated with heart failure (HF). A central component of the remodeling process is the loss of cardiomyocytes via cell death pathways regulated by the mitochondrion. Recent evidence has indicated that exercise training can attenuate or reverse pathological remodeling, creating a physiological phenotype. The purpose of this study was to examine left ventricular (LV) function, remodeling, and cardiomyocyte mitochondrial function in aortic-banded (AB) sedentary (HFSED; n = 6), AB exercise-trained (HFTR, n = 5), and control sedentary (n = 5) male Yucatan miniature swine. LV hypertrophy was present in both AB groups before the start of training, as indicated by increases in LV end-diastolic volume, LV end-systolic volume (LVESV), and LV end-systolic dimension (LVESD). Exercise training (15 wk) prevented further increases in LVESV and LVESD (P < 0.05). The heart weight-to-body weight ratio, LV + septum-to-body weight ratio, LV + septum-to-right ventricle ratio, and cardiomyocyte cross-sectional area were increased in both AB groups postmortem regardless of training status. Preservation of LV function after exercise training, as indicated by the maintenance of fractional shortening, ejection fraction, and mean wall shortening and increased stroke volume, was associated with an attenuation of the increased LV fibrosis (23%) and collagen (36%) observed in HFSED animals. LV mitochondrial dysfunction, as measured by Ca(2+)-induced mitochondrial permeability transition, was increased in HFSED (P < 0.05) but not HFTR animals. In conclusion, low-intensity interval exercise training preserved LV function as exemplified by an attenuation of fibrosis, maintenance of a positive inotropic state, and inhibition of mitochondrial dysfunction, providing further evidence of the therapeutic potential of exercise in a clinical setting.
authors.affiliation: Dept. of Biomedical Science, Univ. of Missouri, 1600 E. Rollins, E117 Veterinary Medicine, Columbia, MO 65211, USA. emterc@missouri.edu
authors.forename: Craig A
authors.initials: CA
authors.lastname: Emter
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Baines
mesh_terms: D000818:Animals; D001013:Aorta, Thoracic; D016923:Cell Death / Q000502:physiology; D004195:Disease Models, Animal; D006333:Heart Failure / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D017379:Hypertrophy, Left Ventricular / Q000473:pathology / Q000503:physiopathology*; D008026:Ligation; D008297:Male; D008929:Mitochondria, Heart / Q000502:physiology*; D032383:Myocytes, Cardiac / Q000473:pathology; D010805:Physical Conditioning, Animal / Q000502:physiology*; D013552:Swine; D013556:Swine, Miniature; D016277:Ventricular Function, Left; D020257:Ventricular Remodeling / Q000502:physiology*
references.citation: J Physiol. 2009 Aug 1;587(Pt 15):3899-910
references.pmid: 19505981
references.citation: J Clin Invest. 2005 Mar;115(3):565-71
references.pmid: 15765138
references.citation: Eur J Clin Invest. 1999 May;29(5):380-6
references.pmid: 10354194
references.citation: Am J Physiol. 1997 Jul;273(1 Pt 2):H487-93
references.pmid: 9249522
references.citation: Hypertension. 2009 Apr;53(4):701-7
references.pmid: 19255362
references.citation: Cardiovasc Res. 2009 Feb 15;81(3):465-73
references.pmid: 18779231
references.citation: Cardiovasc Res. 2003 Dec 1;60(3):617-25
references.pmid: 14659807
references.citation: Nature. 2005 Mar 31;434(7033):652-8
references.pmid: 15800626
references.citation: JAMA. 2000 Jun 21;283(23):3095-101
references.pmid: 10865304
references.citation: Circ Heart Fail. 2009 Sep;2(5):437-45
references.pmid: 19808374
references.citation: Circulation. 2007 Jun 19;115(24):3086-94
references.pmid: 17548726
references.citation: Physiol Rev. 2007 Jan;87(1):99-163
references.pmid: 17237344
references.citation: Cardiovasc Res. 2004 Feb 15;61(3):372-85
references.pmid: 14962470
references.citation: Hypertension. 2007 Aug;50(2):410-6
references.pmid: 17592073
references.citation: Cardiovasc Res. 2005 Jul 1;67(1):21-9
references.pmid: 15896727
references.citation: Am J Physiol Heart Circ Physiol. 2000 Dec;279(6):H2994-3002
references.pmid: 11087257
references.citation: J Biol Chem. 2001 Jan 26;276(4):2571-5
references.pmid: 11073947
references.citation: Circulation. 2009 Aug 18;120(7):577-84
references.pmid: 19652094
references.citation: Hypertension. 2008 Apr;51(4):1096-102
references.pmid: 18259016
references.citation: N Engl J Med. 1997 Apr 17;336(16):1131-41
references.pmid: 9099657
references.citation: Circulation. 1979 Dec;60(6):1308-16
references.pmid: 498456
references.citation: Circulation. 2003 Feb 25;107(7):984-91
references.pmid: 12600911
references.citation: FASEB J. 2006 Apr;20(6):791-3
references.pmid: 16459353
references.citation: J Biol Chem. 2002 Sep 20;277(38):34793-9
references.pmid: 12095984
references.citation: Circ Res. 2006 Mar 3;98(4):540-8
references.pmid: 16439687
references.citation: Physiology (Bethesda). 2007 Feb;22:56-64
references.pmid: 17289931
references.citation: Nature. 2005 Mar 31;434(7033):658-62
references.pmid: 15800627
references.citation: Am J Cardiol. 1976 Jan;37(1):7-11
references.pmid: 1244736
references.citation: J Clin Invest. 2007 Sep;117(9):2431-44
references.pmid: 17694179
references.citation: J Appl Physiol (1985). 2005 Jul;99(1):204-9
references.pmid: 15774698
references.citation: FASEB J. 2008 Aug;22(8):2862-71
references.pmid: 18417547
references.citation: Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H928-35
references.pmid: 18083894
references.citation: J Appl Physiol (1985). 1989 Sep;67(3):1140-9
references.pmid: 2551878
references.citation: Am J Physiol Heart Circ Physiol. 2005 Nov;289(5):H2030-8
references.pmid: 15994855
references.citation: Cardiovasc Res. 2008 Jan 15;77(2):334-43
references.pmid: 18006487
references.citation: Apoptosis. 2009 Apr;14(4):536-48
references.pmid: 19142731
references.citation: N Engl J Med. 1996 Oct 17;335(16):1182-9
references.pmid: 8815940
references.citation: Hypertension. 2000 Nov;36(5):755-9
references.pmid: 11082139
references.citation: Annu Rev Physiol. 2010;72:61-80
references.pmid: 20148667
references.citation: Circulation. 1972 Mar;45(3):602-11
references.pmid: 4258936
references.citation: Am J Physiol Regul Integr Comp Physiol. 2004 Aug;287(2):R247-9
references.pmid: 15789454
references.citation: Circulation. 1978 Dec;58(6):1072-83
references.pmid: 709763
references.citation: J Clin Invest. 2003 May;111(10):1497-504
references.pmid: 12750399
references.citation: Cardiol Clin. 1998 Nov;16(4):691-710, ix
references.pmid: 9891598
references.citation: Am J Physiol Heart Circ Physiol. 2007 Aug;293(2):H903-4
references.pmid: 17513492
references.citation: Circ Res. 1999 Oct 29;85(9):856-66
references.pmid: 10532954
references.citation: Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1322-3
references.pmid: 17630343
references.citation: Hypertension. 2009 Apr;53(4):708-14
references.pmid: 19221208
references.citation: Circulation. 2003 Aug 5;108(5):554-9
references.pmid: 12860904
references.citation: J Mol Cell Cardiol. 2009 Mar;46(3):420-30
references.pmid: 19094991
references.citation: Histochem J. 1979 Jul;11(4):447-55
references.pmid: 91593
references.citation: FASEB J. 2004 Jul;18(10):1150-2
references.pmid: 15132982